ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet


















NIAID workshop: What is a robust PK-PD package?
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
The 6 meanings of “Lack of Access” (UNSLAP)
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
Push! Pull! Push! Pull! / Highlights from Davos 2018
FDA workshop: Insights on inhaled antifungals and antibacterials
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet

The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet